产品简要
公司名称 :
北京义翘神州
产品类型 :
蛋白
产品名称 :
SARS-CoV-2 (2019-nCoV) Spike S2 ECD-His Recombinant Protein
目录 :
40590-V08B
规格 :
100µg
价格 :
448美元
更多信息或购买 :
文章摘录数: 43
参考文献
Buffington J, Duan Z, Kwon H, Hong J, Li D, Feng M, et al. Identification of nurse shark VNAR single-domain antibodies targeting the spike S2 subunit of SARS-CoV-2. FASEB J. 2023;37:e22973 pubmed 出版商
Jia T, Wu Y, Liao G, Lei Y, Wu Z, Yang F, et al. Stable and durable antibody responses in SARS-recovered donors vaccinated with inactivated SARS-CoV-2 vaccine. J Med Virol. 2023;95:e28662 pubmed 出版商
Carre xf1 o J, Raskin A, Singh G, Tcheou J, Kawabata H, Gleason C, et al. An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination. Sci Transl Med. 2023;15:eabo2847 pubmed 出版商
Langel S, Garrido C, Phan C, Travieso T, Kirshner H, DeMarco T, et al. Dam-Infant Rhesus Macaque Pairs to Dissect Age-Dependent Responses to SARS-CoV-2 Infection. Immunohorizons. 2022;6:851-863 pubmed 出版商
LaSalle T, Gonye A, Freeman S, Kaplonek P, Gushterova I, Kays K, et al. Longitudinal characterization of circulating neutrophils uncovers phenotypes associated with severity in hospitalized COVID-19 patients. Cell Rep Med. 2022;3:100779 pubmed 出版商
Jia L, Weng S, Wu J, Tian X, Zhang Y, Wang X, et al. Preexisting antibodies targeting SARS-CoV-2 S2 cross-react with commensal gut bacteria and impact COVID-19 vaccine induced immunity. Gut Microbes. 2022;14:2117503 pubmed 出版商
Sano K, Bhavsar D, Singh G, Floda D, Srivastava K, Gleason C, et al. SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals. Nat Commun. 2022;13:5135 pubmed 出版商
Wang C, Li Y, Kaplonek P, Gentili M, Fischinger S, Bowman K, et al. The Kinetics of SARS-CoV-2 Antibody Development Is Associated with Clearance of RNAemia. MBio. 2022;:e0157722 pubmed 出版商
Junker D, Becker M, Wagner T, Kaiser P, Maier S, Grimm T, et al. Antibody binding and ACE2 binding inhibition is significantly reduced for both the BA1 and BA2 omicron variants. Clin Infect Dis. 2022;: pubmed 出版商
Zimmerman O, Altman Doss A, Kaplonek P, Liang C, Vanblargan L, Chen R, et al. mRNA vaccine boosting enhances antibody responses against SARS-CoV-2 Omicron variant in individuals with antibody deficiency syndromes. Cell Rep Med. 2022;3:100653 pubmed 出版商
Tzeng T, Chai K, Shen K, Yu C, Yang S, Huang W, et al. A DNA vaccine candidate delivered by an electroacupuncture machine provides protective immunity against SARS-CoV-2 infection. NPJ Vaccines. 2022;7:60 pubmed 出版商
Chen Y, Tong P, WHITEMAN N, Moghaddam A, Zarghami M, Zuiani A, et al. Immune recall improves antibody durability and breadth to SARS-CoV-2 variants. Sci Immunol. 2022;:eabp8328 pubmed 出版商
Walters J, Schouest B, Patel A, Reuschel E, Schultheis K, Parzych E, et al. Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates. Vaccine. 2022;40:2960-2969 pubmed 出版商
Wang X, Sanborn M, Dai Y, Rehman J. Temporal transcriptomic analysis using TrendCatcher identifies early and persistent neutrophil activation in severe COVID-19. JCI Insight. 2022;7: pubmed 出版商
Mast F, Fridy P, Ketaren N, Wang J, Jacobs E, Olivier J, et al. Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape. elife. 2021;10: pubmed 出版商
Chang X, Zeltins A, Mohsen M, Gharailoo Z, Zha L, Liu X, et al. A Novel Double Mosaic Virus-like Particle-Based Vaccine against SARS-CoV-2 Incorporates Both Receptor Binding Motif (RBM) and Fusion Domain. Vaccines (Basel). 2021;9: pubmed 出版商
Verma A, Hawes C, Lakshmanappa Y, Roh J, Schmidt B, Dutra J, et al. Monoclonal antibodies protect aged rhesus macaques from SARS-CoV-2-induced immune activation and neuroinflammation. Cell Rep. 2021;37:109942 pubmed 出版商
Langellotto F, Dellacherie M, Yeager C, Ijaz H, Yu J, Cheng C, et al. A Modular Biomaterial Scaffold-Based Vaccine Elicits Durable Adaptive Immunity to Subunit SARS-CoV-2 Antigens. Adv Healthc Mater. 2021;10:e2101370 pubmed 出版商
Shroff R, Chalasani P, Wei R, Pennington D, Quirk G, Schoenle M, et al. Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors. Nat Med. 2021;27:2002-2011 pubmed 出版商
Kramer K, Johnson N, Shiakolas A, Suryadevara N, Periasamy S, Raju N, et al. Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition. Cell Rep. 2021;37:109784 pubmed 出版商
Nassir N, Tambi R, Bankapur A, Al Heialy S, Karuvantevida N, Khansaheb H, et al. Single-cell transcriptome identifies FCGR3B upregulated subtype of alveolar macrophages in patients with critical COVID-19. iScience. 2021;24:103030 pubmed 出版商
Tong P, Gautam A, Windsor I, Travers M, Chen Y, Garcia N, et al. Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike. Cell. 2021;184:4969-4980.e15 pubmed 出版商
Super M, Doherty E, Cartwright M, Seiler B, Langellotto F, Dimitrakakis N, et al. Biomaterial vaccines capturing pathogen-associated molecular patterns protect against bacterial infections and septic shock. Nat Biomed Eng. 2021;: pubmed 出版商
Jennewein M, MacCamy A, Akins N, Feng J, Homad L, Hurlburt N, et al. Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects. Cell Rep. 2021;36:109353 pubmed 出版商
Garrido C, Hurst J, Lorang C, Aquino J, Rodriguez J, Pfeiffer T, et al. Asymptomatic or mild symptomatic SARS-CoV-2 infection elicits durable neutralizing antibody responses in children and adolescents. JCI Insight. 2021;6: pubmed 出版商
Garrido C, Curtis A, Dennis M, Pathak S, Gao H, Montefiori D, et al. SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaques. Sci Immunol. 2021;6: pubmed 出版商
Williams W, Meyerhoff R, Edwards R, Li H, Manne K, Nicely N, et al. Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies. Cell. 2021;184:2955-2972.e25 pubmed 出版商
Youn Y, Lee Y, Kim S, Jin H, Bae J, Hong C. Nucleocapsid and Spike Proteins of SARS-CoV-2 Drive Neutrophil Extracellular Trap Formation. Immune Netw. 2021;21:e16 pubmed 出版商
Mast F, Fridy P, Ketaren N, Wang J, Jacobs E, Olivier J, et al. Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2. bioRxiv. 2021;: pubmed 出版商
Dejnirattisai W, Zhou D, Ginn H, Duyvesteyn H, Supasa P, Case J, et al. The antigenic anatomy of SARS-CoV-2 receptor binding domain. Cell. 2021;184:2183-2200.e22 pubmed 出版商
Bertoglio F, Meier D, Langreder N, Steinke S, Rand U, Simonelli L, et al. SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface. Nat Commun. 2021;12:1577 pubmed 出版商
Gao L, Zhou J, Yang S, Wang L, Chen X, Yang Y, et al. The dichotomous and incomplete adaptive immunity in COVID-19 patients with different disease severity. Signal Transduct Target Ther. 2021;6:113 pubmed 出版商
Pradenas E, Trinit xe9 B, Urrea V, Marfil S, xc1 vila Nieto C, Rodr xed guez de la Concepci xf3 n M, et al. Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes. Med (N Y). 2021;2:313-320.e4 pubmed 出版商
Shaan Lakshmanappa Y, Elizaldi S, Roh J, Schmidt B, Carroll T, Weaver K, et al. SARS-CoV-2 induces robust germinal center CD4 T follicular helper cell responses in rhesus macaques. Nat Commun. 2021;12:541 pubmed 出版商
Zohar T, Loos C, Fischinger S, Atyeo C, Wang C, Slein M, et al. Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality. Cell. 2020;183:1508-1519.e12 pubmed 出版商
Chen Y, Zuiani A, Fischinger S, Mullur J, Atyeo C, Travers M, et al. Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production. Cell. 2020;183:1496-1507.e16 pubmed 出版商
Ripperger T, Uhrlaub J, Watanabe M, Wong R, Castaneda Y, Pizzato H, et al. Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity. Immunity. 2020;53:925-933.e4 pubmed 出版商
Sohn K, Lee S, Kim H, Cheon S, Jeong H, Lee J, et al. COVID-19 Patients Upregulate Toll-like Receptor 4-mediated Inflammatory Signaling That Mimics Bacterial Sepsis. J Korean Med Sci. 2020;35:e343 pubmed 出版商
Elizaldi S, Lakshmanappa Y, Roh J, Schmidt B, Carroll T, Weaver K, et al. SARS-CoV-2 infection induces robust germinal center CD4 T follicular helper cell responses in rhesus macaques. Res Sq. 2020;: pubmed 出版商
Elizaldi S, Lakshmanappa Y, Roh J, Schmidt B, Carroll T, Weaver K, et al. SARS-CoV-2 infection induces germinal center responses with robust stimulation of CD4 T follicular helper cells in rhesus macaques. bioRxiv. 2020;: pubmed 出版商
Acharya P, Williams W, Henderson R, Janowska K, Manne K, Parks R, et al. A glycan cluster on the SARS-CoV-2 spike ectodomain is recognized by Fab-dimerized glycan-reactive antibodies. bioRxiv. 2020;: pubmed 出版商
Feng S, Luan X, Wang Y, Wang H, Zhang Z, Wang Y, et al. Eltrombopag is a potential target for drug intervention in SARS-CoV-2 spike protein. Infect Genet Evol. 2020;85:104419 pubmed 出版商
Ravichandran S, Coyle E, Klenow L, Tang J, Grubbs G, Liu S, et al. Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits. Sci Transl Med. 2020;12: pubmed 出版商
图像
图像 1 :
北京义翘神州 40590-V08B 图像 1
产品信息
目录代码 :
40590-V08B
产品名称 :
SARS-CoV-2 (2019-nCoV) Spike S2 ECD-His Recombinant Protein
产品类型 :
蛋白
宿主物种 :
杆状病毒昆虫细胞
共轭 :
C多聚组氨酸
规格 :
100µg
标价 :
448美元
基因编号 :
YP_009724390.1
产品描述 :
A DNA sequence encoding the SARS-CoV-2 (2019-nCoV) Spike Protein (S2 ECD) (YP_009724390.1) (Ser686-Pro1213) was expressed with a polyhistidine tag at the C-terminus.
物种摘要 :
SARS-CoV-2
别名 :
Spike
纯度 :
> 90 % as determined by SDS-PAGE.
缓冲液 :
Lyophilized from sterile 20 mM PB, 300 mM NaCl, 10 % glycerol, pH 7.0.
包装 :
In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature. Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.
储存 :
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
更多信息或购买 :
公司信息
北京义翘神州
北京市北京经济技术开发区科创十街18号院9号楼
Order@Sinobiological.com
http://www.sinobiological.cn
400-890-9989
公司总部: 中国
北京义翘神州科技股份有限公司(Sino Biological Inc.)是一家从事生物试剂研发、生产、销售并提供技术服务的生物科技公司,主要业务有重组蛋白、抗体、基因和培养基等产品,以及重组蛋白、抗体的开发和生物分析检测等服务。

义翘科技为全球的药品研发企业和生命科学研究机构提供高质量的生物试剂产品和高水平的技术服务。义翘科技目前生产和销售的现货产品种类超过4.6万种,能够全面满足客户对于最接近人体天然蛋白结构和性质的重组蛋白需求,并覆盖生命科学研究的多个领域,为分子生物学、细胞生物学、免疫学、发育生物学、干细胞研究等基础科研方向和创新药物研发提供“一站式”生物试剂产品和技术服务。

义翘科技的客户涵盖大学、科研院所、医药研发企业等国内外各类生物研发单位。目前公司已经在美国、欧洲建立了子公司,累计客户数量超过5,000个,品牌声誉不断累积,已成为生物试剂行业国内领先的科技公司之一。